Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05089162

CHF-COV Reduced (Chronic Heart Failure With Reduced Ejection Fraction - COngestion eValuation)

Evaluation de la Congestion en Hospitalisation de Jour Pour un Bilan d'Insuffisance Cardiaque Chronique à Fraction d'éjection altérée ou modérément altérée CHF-COV Reduced (Chronic Heart Failure With Reduced Ejection Fraction - COngestion eValuation)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Pr. Nicolas GIRERD · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Heart failure (HF) is a significant cause of death and the leading cause of hospitalization in patients over 65 years of age. Congestion is the main source of symptoms and the leading cause of hospitalization for HF. Furthermore, congestive signs identified in asymptomatic patients are associated with the risk of developing symptomatic HF. The literature supports a multi-modality / integrative evaluation of congestion, combining clinical examination, laboratory results and ultrasound evaluation. The main objective of the CHF-COVReduced study is to identify congestion markers (clinical, biological and ultrasound) quantified during a consultation or day hospitalization for the monitoring of chronic HF with reduced left ventricular ejection fraction that are associated with the risk of all-cause death, hospitalization for acute HF or IV diuretics injection in a day hospital.

Conditions

Interventions

TypeNameDescription
PROCEDUREClinical examination centered on congestionClinical examination centered on congestion (including the EVEREST, ASCEND and Ambrosy scores) will be performed during day hospitalization or consultation
PROCEDURECardiac, pulmonary, peritoneal, jugular and renal Doppler ultrasoundsCardiac, pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography will be performed during day hospitalization or consultation/ peritoneal, jugular and renal Doppler ultrasounds are optional
PROCEDUREBlood sample retrieved for biological assessment and biobankingBlood sample retrieved for biological assessment and biobanking will be performed during day hospitalization or consultation
OTHERTelephone follow-upTelephone follow-up will be performed 3, 12 and 24 months after day hospitalization or consultation
BEHAVIORALKansas City Cardiomyopathy Questionnaire (KCCQ)Questionnaire centered on patient's quality of life at discharge and 3, 12 and 24 months after discharge

Timeline

Start date
2021-12-14
Primary completion
2028-12-14
Completion
2029-06-14
First posted
2021-10-22
Last updated
2023-06-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05089162. Inclusion in this directory is not an endorsement.